2024 Q1 Form 10-K Financial Statement

#000155837024001998 Filed on February 28, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $228.2M $224.3M $831.1M
YoY Change 18.84% 22.21% 32.42%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $74.10M $78.89M $297.6M
YoY Change -0.55% -4.02% 16.89%
% of Gross Profit
Research & Development $32.05M $34.97M $119.2M
YoY Change 9.46% 6.29% 3.61%
% of Gross Profit
Depreciation & Amortization $9.408M $8.750M $27.81M
YoY Change 55.79% 64.07% 33.35%
% of Gross Profit
Operating Expenses $189.8M $198.6M $727.5M
YoY Change 7.23% 3.38% 11.95%
Operating Profit $38.38M $103.6M
YoY Change 155.64% -566.41%
Interest Expense $4.508M $28.93M
YoY Change 114.87% 21.38%
% of Operating Profit 11.75% 27.92%
Other Income/Expense, Net $4.508M $15.59M $28.93M
YoY Change 114.87% 158.23% 21.38%
Pretax Income $42.88M $41.29M $132.5M
YoY Change 150.64% -1733.43% 8091.35%
Income Tax $13.91M $14.27M $39.20M
% Of Pretax Income 32.44% 34.56% 29.58%
Net Earnings $28.97M $27.02M $93.33M
YoY Change 265.0% -366.19% -879.72%
Net Earnings / Revenue 12.7% 12.05% 11.23%
Basic Earnings Per Share $0.08 $0.26
Diluted Earnings Per Share $0.08 $0.07 $0.24
COMMON SHARES
Basic Shares Outstanding 368.8M 361.8M 361.7M
Diluted Shares Outstanding 378.7M 392.7M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $587.2M $617.0M $617.0M
YoY Change 7.83% 13.57% 13.57%
Cash & Equivalents $587.2M $617.0M $617.0M
Short-Term Investments
Other Short-Term Assets $40.78M $40.67M $6.425B
YoY Change -8.4% 12.11% 9.52%
Inventory
Prepaid Expenses
Receivables $7.224M $7.980M $7.980M
Other Receivables $60.56M $58.34M $58.34M
Total Short-Term Assets $6.616B $7.109B $7.109B
YoY Change 8.13% 9.85% 9.85%
LONG-TERM ASSETS
Property, Plant & Equipment $14.90M $15.50M $40.35M
YoY Change 3.91% 7.69% 36.09%
Goodwill $19.89M $19.89M
YoY Change 0.0% 0.0%
Intangibles $82.65M $76.27M
YoY Change 65.08% 67.82%
Long-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets $15.80M $15.98M $37.89M
YoY Change 41.69% 32.91% 71.18%
Total Long-Term Assets $179.3M $174.4M $174.4M
YoY Change 50.76% 41.16% 41.16%
TOTAL ASSETS
Total Short-Term Assets $6.616B $7.109B $7.109B
Total Long-Term Assets $179.3M $174.4M $174.4M
Total Assets $6.795B $7.283B $7.283B
YoY Change 8.94% 10.44% 10.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $35.30M $33.94M $33.94M
YoY Change 11.11% -18.34% -18.34%
Accrued Expenses $9.652M $12.36M $87.37M
YoY Change 7.11% 23.57% -8.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.060B $6.542B $6.542B
YoY Change 8.49% 9.44% 9.44%
LONG-TERM LIABILITIES
Long-Term Debt $14.43M $18.41M $18.41M
YoY Change -15.72% 14.08% 14.08%
Other Long-Term Liabilities $52.57M $49.91M $58.46M
YoY Change 66.93% 67.29% 4.87%
Total Long-Term Liabilities $67.00M $68.32M $76.87M
YoY Change 37.83% 48.61% 6.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.060B $6.542B $6.542B
Total Long-Term Liabilities $67.00M $68.32M $76.87M
Total Liabilities $6.134B $6.619B $6.619B
YoY Change 8.36% 9.41% 9.41%
SHAREHOLDERS EQUITY
Retained Earnings $13.78M -$15.20M
YoY Change -113.7% -86.0%
Common Stock $3.773M $3.687M
YoY Change 5.04% 4.51%
Preferred Stock
YoY Change
Treasury Stock (at cost) $108.1M $56.94M
YoY Change
Treasury Stock Shares
Shareholders Equity $661.5M $664.3M $664.3M
YoY Change
Total Liabilities & Shareholders Equity $6.795B $7.283B $7.283B
YoY Change 8.94% 10.44% 10.44%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $28.97M $27.02M $93.33M
YoY Change 265.0% -366.19% -879.72%
Depreciation, Depletion And Amortization $9.408M $8.750M $27.81M
YoY Change 55.79% 64.07% 33.35%
Cash From Operating Activities $39.51M $58.16M $159.5M
YoY Change 912.56% 46.75% 89.96%
INVESTING ACTIVITIES
Capital Expenditures $1.616M $18.13M $8.459M
YoY Change -8.39% 57.8% -19.47%
Acquisitions
YoY Change
Other Investing Activities -$98.48M $21.63M $3.538M
YoY Change 106.66% -30.59% -89.76%
Cash From Investing Activities -$114.1M $3.500M -$44.25M
YoY Change 100.24% -82.21% -871.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $55.44M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -521.1M 1.005B 512.0M
YoY Change 42.97% 24.72% -64.97%
NET CHANGE
Cash From Operating Activities 39.51M 58.16M 159.5M
Cash From Investing Activities -114.1M 3.500M -44.25M
Cash From Financing Activities -521.1M 1.005B 512.0M
Net Change In Cash -597.3M 1.066B 631.6M
YoY Change 43.21% 23.29% -59.2%
FREE CASH FLOW
Cash From Operating Activities $39.51M $58.16M $159.5M
Capital Expenditures $1.616M $18.13M $8.459M
Free Cash Flow $37.89M $40.03M $151.0M
YoY Change 1672.4% 42.23% 105.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001845815
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity Registrant Name
EntityRegistrantName
Payoneer Global Inc.
CY2023 dei Entity File Number
EntityFileNumber
001-40547
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1778671
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
150 W 30th St
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10001
CY2023 dei City Area Code
CityAreaCode
212
CY2023 dei Local Phone Number
LocalPhoneNumber
600-9272
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
1474988741
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
368751080
CY2023 dei Auditor Firm
AuditorFirmId
1309
CY2023 dei Auditor Name
AuditorName
Kesselman & Kesselman
CY2023 dei Auditor Location
AuditorLocation
Tel Aviv, Israel
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
617022000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
543299000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7030000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2882000
CY2023Q4 payo Customer Funds Current
CustomerFundsCurrent
6390526000
CY2022Q4 payo Customer Funds Current
CustomerFundsCurrent
5838612000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
385000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
246000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7980000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12878000
CY2023Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
5059000
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
5311000
CY2023Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
45493000
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
37155000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
40672000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
36278000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
7108723000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
6471104000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15499000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14392000
CY2023Q4 us-gaap Goodwill
Goodwill
19889000
CY2022Q4 us-gaap Goodwill
Goodwill
19889000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
76266000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
45444000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5780000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
4848000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
15291000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4169000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
6429000
CY2023Q4 payo Severance Pay Fund Non Current
SeverancePayFundNonCurrent
840000
CY2022Q4 payo Severance Pay Fund Non Current
SeverancePayFundNonCurrent
1095000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24854000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15260000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15977000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12021000
CY2023Q4 us-gaap Assets
Assets
7283119000
CY2022Q4 us-gaap Assets
Assets
6594651000
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
33941000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
41566000
CY2023Q4 payo Outstanding Operating Balances Current
OutstandingOperatingBalancesCurrent
6390526000
CY2022Q4 payo Outstanding Operating Balances Current
OutstandingOperatingBalancesCurrent
5838612000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
117508000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
97334000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6541975000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5977512000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18411000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
16138000
CY2023Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
8555000
CY2022Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
25914000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
49905000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29831000
CY2023Q4 us-gaap Liabilities
Liabilities
6618846000
CY2022Q4 us-gaap Liabilities
Liabilities
6049395000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
380000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
380000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3800000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3800000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
368655185
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
352842025
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
357590493
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
352842025
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3687000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3528000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
11064692
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
56936000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
732894000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
650433000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-176000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-176000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15196000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-108529000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
664273000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
545256000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7283119000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6594651000
CY2023 us-gaap Revenues
Revenues
831103000
CY2022 us-gaap Revenues
Revenues
627623000
CY2021 us-gaap Revenues
Revenues
473403000
CY2023 payo Transaction Costs
TransactionCosts
122291000
CY2022 payo Transaction Costs
TransactionCosts
110165000
CY2021 payo Transaction Costs
TransactionCosts
101476000
CY2023 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-160609000
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-149199000
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-124649000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
119197000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
115041000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
80760000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
196654000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
164564000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
114331000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
100929000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
90010000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64399000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27814000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20858000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17997000
CY2023 us-gaap Operating Expenses
OperatingExpenses
727494000
CY2022 us-gaap Operating Expenses
OperatingExpenses
649837000
CY2021 us-gaap Operating Expenses
OperatingExpenses
503612000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
103609000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-22214000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-30209000
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-17359000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-33963000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11824000
CY2023 payo Other Interest Income Expense Nonoperating Net
OtherInterestIncomeExpenseNonoperatingNet
11568000
CY2022 payo Other Interest Income Expense Nonoperating Net
OtherInterestIncomeExpenseNonoperatingNet
-10131000
CY2021 payo Other Interest Income Expense Nonoperating Net
OtherInterestIncomeExpenseNonoperatingNet
-6854000
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
28927000
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
23832000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4970000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
132536000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1618000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25239000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39203000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13586000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8711000
CY2022 payo Income Loss From Equity Method Investments Affecting Cash Flow Statement
IncomeLossFromEquityMethodInvestmentsAffectingCashFlowStatement
2000
CY2021 payo Income Loss From Equity Method Investments Affecting Cash Flow Statement
IncomeLossFromEquityMethodInvestmentsAffectingCashFlowStatement
37000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
93333000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11970000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-33987000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2429000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1921000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2429000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1921000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
93333000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14399000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35908000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
361678893
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
348044831
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
202881911
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
392665718
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
348044831
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
202881911
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
24299000
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
-191554000
CY2021 payo Private Investment In Public Equity Financing Vlaue
PrivateInvestmentInPublicEquityFinancingVlaue
280185000
CY2021 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
29069000
CY2021 payo Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits
19000000
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
37012000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1921000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-33987000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
487073000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
487073000
CY2022 payo Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits
17506000
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
53741000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3840000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2429000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11970000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
545256000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
545256000
CY2023 payo Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits
6469000
CY2023 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
69028000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
7123000
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
56936000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
93333000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
664273000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
93333000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11970000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-33987000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27814000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20858000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20015000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17997000
CY2023 payo Adjustment To Operating Cash Flows Deferred Income Taxes
AdjustmentToOperatingCashFlowsDeferredIncomeTaxes
-11122000
CY2022 payo Adjustment To Operating Cash Flows Deferred Income Taxes
AdjustmentToOperatingCashFlowsDeferredIncomeTaxes
731000
CY2021 payo Adjustment To Operating Cash Flows Deferred Income Taxes
AdjustmentToOperatingCashFlowsDeferredIncomeTaxes
-1216000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
65767000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
52149000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
37012000
CY2022 payo Income Loss From Equity Method Investments Affecting Cash Flow Statement
IncomeLossFromEquityMethodInvestmentsAffectingCashFlowStatement
2000
CY2021 payo Income Loss From Equity Method Investments Affecting Cash Flow Statement
IncomeLossFromEquityMethodInvestmentsAffectingCashFlowStatement
37000
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-17359000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-33963000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11824000
CY2021 payo Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
-5087000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4359000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2752000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1103000
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
4310000
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
11421000
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
14694000
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-8326000
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
24284000
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
469000
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1348000
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
224000
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-432000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4898000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-964000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3933000
CY2023 payo Increase Decrease In Capital Advance Extended To Customers
IncreaseDecreaseInCapitalAdvanceExtendedToCustomers
-299139000
CY2022 payo Increase Decrease In Capital Advance Extended To Customers
IncreaseDecreaseInCapitalAdvanceExtendedToCustomers
-223819000
CY2021 payo Increase Decrease In Capital Advance Extended To Customers
IncreaseDecreaseInCapitalAdvanceExtendedToCustomers
-330510000
CY2023 payo Increase Decrease In Capital Advance Collected From Customers
IncreaseDecreaseInCapitalAdvanceCollectedFromCustomers
-290801000
CY2022 payo Increase Decrease In Capital Advance Collected From Customers
IncreaseDecreaseInCapitalAdvanceCollectedFromCustomers
-237834000
CY2021 payo Increase Decrease In Capital Advance Collected From Customers
IncreaseDecreaseInCapitalAdvanceCollectedFromCustomers
-342930000
CY2023 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
13619000
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
16608000
CY2021 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
691000
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
232000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3480000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-4775000
CY2023 payo Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
-10248000
CY2022 payo Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
-10686000
CY2021 payo Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
-9525000
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
3956000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1521000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1331000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
159489000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
83960000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8459000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10504000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6891000
CY2023 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
39333000
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
18329000
CY2021 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
14008000
CY2023 payo Payments For Related Party Asset Acquisition
PaymentsForRelatedPartyAssetAcquisition
3600000
CY2023 payo Change In Severance Pay Fund Investing Activities
ChangeInSeverancePayFundInvestingActivities
255000
CY2022 payo Change In Severance Pay Fund Investing Activities
ChangeInSeverancePayFundInvestingActivities
628000
CY2021 payo Change In Severance Pay Fund Investing Activities
ChangeInSeverancePayFundInvestingActivities
-99000
CY2023 payo Customer Funds In Transit Investing Activities
CustomerFundsInTransitInvestingActivities
930000
CY2022 payo Customer Funds In Transit Investing Activities
CustomerFundsInTransitInvestingActivities
33939000
CY2021 payo Customer Funds In Transit Investing Activities
CustomerFundsInTransitInvestingActivities
31154000
CY2023 payo Business Combination Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
BusinessCombinationCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5953000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44254000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5734000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10156000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13203000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21346000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19000000
CY2023 payo Proceeds From Outstanding Operating Balances
ProceedsFromOutstandingOperatingBalances
551914000
CY2022 payo Proceeds From Outstanding Operating Balances
ProceedsFromOutstandingOperatingBalances
1437358000
CY2021 payo Proceeds From Outstanding Operating Balances
ProceedsFromOutstandingOperatingBalances
1054530000
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
26855000
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
29363000
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
17431000
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
24582000
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
26755000
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
3766000
CY2021 payo Repayments Under Receivables And Loan Security Agreement
RepaymentsUnderReceivablesAndLoanSecurityAgreement
40025000
CY2021 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
39803000
CY2021 payo Reverse Recapitalization Financing
ReverseRecapitalizationFinancing
108643000
CY2021 payo Private Investment In Public Equity Financing Vlaue
PrivateInvestmentInPublicEquityFinancingVlaue
280185000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
55436000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
511954000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1461312000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1396195000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4458000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2719000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1222000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
631647000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1548287000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1425144000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6386720000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4838433000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3413289000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7018367000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6386720000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4838433000
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
40910000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
9425000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
3689000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
1767000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1466000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1919000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
810000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
109000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
20000
CY2023 payo Expenditure For Internal Use Software Capitalized But Not Paid
ExpenditureForInternalUseSoftwareCapitalizedButNotPaid
10159000
CY2022 payo Expenditure For Internal Use Software Capitalized But Not Paid
ExpenditureForInternalUseSoftwareCapitalizedButNotPaid
4392000
CY2021 payo Expenditure For Internal Use Software Capitalized But Not Paid
ExpenditureForInternalUseSoftwareCapitalizedButNotPaid
1560000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
19842000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13003000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3188000
CY2023 payo Common Stock Repurchased But Not Yet Paid
CommonStockRepurchasedButNotYetPaid
1500000
CY2021 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
154800000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
617022000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
543299000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
465926000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7030000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2882000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
3000000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5780000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
4848000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5113000
CY2023Q4 us-gaap Customer Funds
CustomerFunds
6388535000
CY2022Q4 us-gaap Customer Funds
CustomerFunds
5835691000
CY2021Q4 us-gaap Customer Funds
CustomerFunds
4364394000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7018367000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6386720000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4838433000
CY2023Q4 payo Customer Funds In Transit
CustomerFundsInTransit
1991000
CY2022Q4 payo Customer Funds In Transit
CustomerFundsInTransit
2921000
CY2021Q4 payo Customer Funds In Transit
CustomerFundsInTransit
36860000
CY2021 payo Cash Held By Ftoc And Cash Related To Ftoc Trust Net Of Redemptions
CashHeldByFtocAndCashRelatedToFtocTrustNetOfRedemptions
574961000
CY2021 payo Cash Consideration Of Legacy Payoneer Shareholders
CashConsiderationOfLegacyPayoneerShareholders
398201000
CY2021 payo Cash Paid Associated With Transaction Cost
CashPaidAssociatedWithTransactionCost
68117000
CY2021 payo Reverse Recapitalization Financing
ReverseRecapitalizationFinancing
108643000
CY2021 payo Cash Related To Pipe
CashRelatedToPipe
300000000
CY2021 payo Cashpaidassociatedwithtransactioncostsallocated To Private Investment In Public Equity Financing
CashpaidassociatedwithtransactioncostsallocatedToPrivateInvestmentInPublicEquityFinancing
19815000
CY2021 payo Private Investment In Public Equity Financing
PrivateInvestmentInPublicEquityFinancing
280185000
CY2021 payo Net Contributions From Reverse Recapitalization And Pipe Financing
NetContributionsFromReverseRecapitalizationAndPipeFinancing
388828000
CY2023Q4 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
190
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 payo Exchange Ratio Reverse Recapitalization
ExchangeRatioReverseRecapitalization
1.88
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">b.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">Use of estimates in the preparation of financial statements:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include, but are not limited to, allowance for capital advance receivables, income taxes, goodwill, revenue recognition, stock-based compensation, and loss contingencies. </p>
CY2023 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
5628000
CY2023Q4 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P1Y10M2D
CY2021 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2022 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2023 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q4 payo Allowance For Transaction Losses
AllowanceForTransactionLosses
7418000
CY2022Q4 payo Allowance For Transaction Losses
AllowanceForTransactionLosses
6617000
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
23878000
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
23985000
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
9330000
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<table style="border-collapse:collapse;border:0;"><tr><td style="width:18pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">z.</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:12pt;margin-top:0pt;">Concentration of risks:</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Credit risk concentration</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, customer funds, restricted cash, and accounts receivable. The Company’s assets are held with financial institutions throughout the world. The Company regularly reviews its relative exposure to financial and other institutions and has relationships with a globally diversified group of banks and financial institutions. A significant portion of the Company’s funds are deposited at large depository institutions and global systematically important banks. The vast majority of those cash funds exceed applicable FDIC coverage insurance limits of $250 or are held with financial institutions in countries that do not offer deposit insurance and are subject to specific institutional, regional and country risks. The Company is also exposed to transaction losses due to funds blocked with its global bank transfers processors. See also Note 16.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">62% and 68% of the Company’s cash and cash equivalents and customer funds are concentrated with U.S. financial institutions as of December 31, 2023 and 2022, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">Cash and cash equivalents and customer funds balances denominated in U.S. dollars represent 77% and 76% of the balance of the cash, cash equivalents and customer funds at December 31, 2023, and 2022, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vendor concentration</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;">The Company issues cards directly under its Mastercard license and utilizes a third-party issuing bank for issuance to customers in the United States and for its corporate purchasing card service. If the issuing bank ceases to transact with current cardholders, experiences a significant disruption that affects current cardholder transactions, or ceases to operate as an issuing bank due to circumstances outside of the Company’s control, or if Mastercard revokes the Company’s license to issue cards, the Company’s financial condition and operating results could be significantly impacted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Marketplace and customer concentration</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">In 2023, revenues associated with two individual marketplaces represented 11% and 25%, respectively, of total revenue. In  2022, revenues associated with two individual marketplaces represented 13% and 23%, respectively, of total revenue. In 2021, revenues associated with a <span style="-sec-ix-hidden:Hidden_GpgP6g4vfUi35NHwHvdgBA;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">single marketplace</span></span> represented 30% of total revenue. Note that in 2023, the Company updated its methodology for allocating revenues derived from usage to volumes attributable to individual marketplaces, which resulted in increased revenue allocated to certain individual marketplaces. Prior period numbers have been updated to conform to current period presentation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (continued):</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">In 2023, 2022 and 2021, revenues generated from customers who reside in Greater China constituted 35%, 31% and 34%, respectively, of total revenues. This geographic concentration creates exposure to local economic and political conditions, and to economic downturns in the markets serviced by customers who reside in Greater China. Any unforeseen events or changes in regulation or legal requirements in Greater China that restrict the services the Company can provide to customers who reside in Greater China could have a material impact on the Company’s financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 36pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Geographical employee concentration</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 36pt;">In October 2023, in response to Hamas’ attack on Israel from the Gaza Strip, Israel declared war on Hamas. Approximately 60% of the Company’s global employee base is located in Israel, including approximately 80% of its research and development resources. At this time, an insignificant amount of the Company’s Israeli workforce have been called to military reserve duty and the Company has contingencies in place to cover impacted roles and responsibilities. </p>
CY2023 payo Percentage Of Concentration Of Domestic Financial Institutions In Cash And Cash Equivalents Customer Funds
PercentageOfConcentrationOfDomesticFinancialInstitutionsInCashAndCashEquivalentsCustomerFunds
0.62
CY2022 payo Percentage Of Concentration Of Domestic Financial Institutions In Cash And Cash Equivalents Customer Funds
PercentageOfConcentrationOfDomesticFinancialInstitutionsInCashAndCashEquivalentsCustomerFunds
0.68
CY2023 payo Percentage Of Cash And Cash Equivalents Customer Funds Denominated In U.S Dollars
PercentageOfCashAndCashEquivalentsCustomerFundsDenominatedInU.sDollars
0.77
CY2022 payo Percentage Of Cash And Cash Equivalents Customer Funds Denominated In U.S Dollars
PercentageOfCashAndCashEquivalentsCustomerFundsDenominatedInU.sDollars
0.76
CY2021Q2 payo Exchange Ratio Reverse Recapitalization
ExchangeRatioReverseRecapitalization
1.88
CY2021Q2 payo Reverse Recapitalization Cash Consideration Paid
ReverseRecapitalizationCashConsiderationPaid
398201000
CY2021Q2 payo Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
4180000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3800000000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
380000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
71701000
CY2021Q2 payo Amount Of Cost Incurred Reverse Recapitalization And Pipe Offering
AmountOfCostIncurredReverseRecapitalizationAndPipeOffering
64271000
CY2021Q2 payo Transaction Costs Associated With Warrants
TransactionCostsAssociatedWithWarrants
5087000
CY2021Q2 payo Deferred Underwriting Costs Related To Ftoc
DeferredUnderwritingCostsRelatedToFtoc
28934000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49697982
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
8854131
CY2021Q2 payo Common Stock Outstanding Prior To Reverse Recapitalization
CommonStockOutstandingPriorToReverseRecapitalization
58552113
CY2021Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
209529798
CY2021Q2 payo Common Stock Subject To Cash Out
CommonStockSubjectToCashOut
-36818547
CY2021Q2 payo Common Stock Attributable To Ftoc Conversion
CommonStockAttributableToFtocConversion
77081295
CY2021Q2 payo Shares Attributable To Reverse Recapitalization
SharesAttributableToReverseRecapitalization
308344659
CY2021Q2 payo Private Investment In Pubic Equity Financing Shares
PrivateInvestmentInPubicEquityFinancingShares
30000000
CY2021Q2 payo Common Stock Attributable To Reverse Recapitalization And Pipe Transaction
CommonStockAttributableToReverseRecapitalizationAndPipeTransaction
338344659
CY2022Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
42466000
CY2021Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
56101000
CY2023 payo Financing Receivable Extended To Customers
FinancingReceivableExtendedToCustomers
-298467000
CY2022 payo Financing Receivable Extended To Customers
FinancingReceivableExtendedToCustomers
-237825000
CY2023 payo Financing Receivable Increase In Revenue Receivables
FinancingReceivableIncreaseInRevenueReceivables
420000
CY2022 payo Financing Receivable Increase In Revenue Receivables
FinancingReceivableIncreaseInRevenueReceivables
-9000
CY2023 payo Financing Receivable Collected From Customers
FinancingReceivableCollectedFromCustomers
-285530000
CY2022 payo Financing Receivable Collected From Customers
FinancingReceivableCollectedFromCustomers
-248932000
CY2023 payo Financing Receivable Charge Offs Net Of Recoveries
FinancingReceivableChargeOffsNetOfRecoveries
-5271000
CY2022 payo Financing Receivable Charge Offs Net Of Recoveries
FinancingReceivableChargeOffsNetOfRecoveries
-2519000
CY2023Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
50552000
CY2022Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
42466000
CY2023Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
5059000
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
5311000
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
45493000
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
37155000
CY2023Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
50552000
CY2022Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
42466000
CY2023Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
50552000
CY2022Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
42466000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5311000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2426000
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-5227000
CY2022 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-4357000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
208000
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
1458000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
5271000
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
2519000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5059000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5311000
CY2023Q4 payo Prepaid Expense Except Taxes Current
PrepaidExpenseExceptTaxesCurrent
16656000
CY2022Q4 payo Prepaid Expense Except Taxes Current
PrepaidExpenseExceptTaxesCurrent
12155000
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
12844000
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
11162000
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
8136000
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
7671000
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
3036000
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
5290000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
40672000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
36278000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54805000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
48487000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
39306000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34095000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15499000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14392000
CY2023 us-gaap Depreciation
Depreciation
8056000
CY2022 us-gaap Depreciation
Depreciation
8285000
CY2021 us-gaap Depreciation
Depreciation
7057000
CY2023 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
2915000
CY2022 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
7477000
CY2023 payo Property Plant And Equipment Net Book Value Disposals
PropertyPlantAndEquipmentNetBookValueDisposals
11000
CY2022 payo Property Plant And Equipment Net Book Value Disposals
PropertyPlantAndEquipmentNetBookValueDisposals
43000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15499000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14392000
CY2021Q4 us-gaap Goodwill
Goodwill
21127000
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1238000
CY2022Q4 us-gaap Goodwill
Goodwill
19889000
CY2023Q4 us-gaap Goodwill
Goodwill
19889000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
139916000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
63650000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
76266000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
89560000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
44116000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
45444000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19434000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11959000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10826000
CY2023Q4 payo Capitalized Internal Use Software Not Yet Placed In Service
CapitalizedInternalUseSoftwareNotYetPlacedInService
24164000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1501000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1430000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
309000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
10122000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
11224000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
10420000
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
11623000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
12654000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
10729000
CY2023 payo Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
-10248000
CY2022 payo Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
-10686000
CY2021 payo Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
-9525000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24854000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15260000
CY2023Q4 payo Operating Lease Liabilities Within Other Current Payables
OperatingLeaseLiabilitiesWithinOtherCurrentPayables
7171000
CY2022Q4 payo Operating Lease Liabilities Within Other Current Payables
OperatingLeaseLiabilitiesWithinOtherCurrentPayables
8360000
CY2023Q4 payo Operating Lease Liabilities Within Long Term Payables
OperatingLeaseLiabilitiesWithinLongTermPayables
17836000
CY2022Q4 payo Operating Lease Liabilities Within Long Term Payables
OperatingLeaseLiabilitiesWithinLongTermPayables
6514000
CY2023Q4 payo Operating Lease Liabilities Classified Within Current And Long Term Liabilities
OperatingLeaseLiabilitiesClassifiedWithinCurrentAndLongTermLiabilities
25007000
CY2022Q4 payo Operating Lease Liabilities Classified Within Current And Long Term Liabilities
OperatingLeaseLiabilitiesClassifiedWithinCurrentAndLongTermLiabilities
14874000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M9D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y11M26D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0606
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0267
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7050000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5364000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2859000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1923000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1923000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
12372000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
31491000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6484000
CY2023Q4 payo Operating Lease Liabilities Classified Within Current And Long Term Liabilities
OperatingLeaseLiabilitiesClassifiedWithinCurrentAndLongTermLiabilities
25007000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
67837000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
64464000
CY2023Q4 payo Commission Payable Current
CommissionPayableCurrent
23695000
CY2022Q4 payo Commission Payable Current
CommissionPayableCurrent
12159000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12358000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10001000
CY2023Q4 payo Operating Lease Liabilities Within Other Current Payables
OperatingLeaseLiabilitiesWithinOtherCurrentPayables
7171000
CY2022Q4 payo Operating Lease Liabilities Within Other Current Payables
OperatingLeaseLiabilitiesWithinOtherCurrentPayables
8360000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2410000
CY2023Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
4037000
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
2350000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
117508000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
97334000
CY2023Q4 payo Assets Pledged As Collateral And Included Within Capital Advance Receivables
AssetsPledgedAsCollateralAndIncludedWithinCapitalAdvanceReceivables
32468000
CY2022Q4 payo Assets Pledged As Collateral And Included Within Capital Advance Receivables
AssetsPledgedAsCollateralAndIncludedWithinCapitalAdvanceReceivables
25906000
CY2023Q4 payo Reserves For Uncertain Tax Positions
ReservesForUncertainTaxPositions
24793000
CY2022Q4 payo Reserves For Uncertain Tax Positions
ReservesForUncertainTaxPositions
17332000
CY2023Q4 payo Operating Lease Liability Long Term
OperatingLeaseLiabilityLongTerm
17836000
CY2022Q4 payo Operating Lease Liability Long Term
OperatingLeaseLiabilityLongTerm
6514000
CY2023Q4 payo Non Current Tax Provisions Other
NonCurrentTaxProvisionsOther
5202000
CY2022Q4 payo Non Current Tax Provisions Other
NonCurrentTaxProvisionsOther
3716000
CY2023Q4 payo Severance Pay Liabilities Noncurrent
SeverancePayLiabilitiesNoncurrent
2056000
CY2022Q4 payo Severance Pay Liabilities Noncurrent
SeverancePayLiabilitiesNoncurrent
2252000
CY2023Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
18000
CY2022Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
17000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
49905000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29831000
CY2023Q3 payo Restructuring And Related Activities Reduction In Workforce Percentage
RestructuringAndRelatedActivitiesReductionInWorkforcePercentage
0.09
CY2023 us-gaap Restructuring Charges
RestructuringCharges
4488000
CY2023Q4 us-gaap Postemployment Benefits Liability Current And Noncurrent
PostemploymentBenefitsLiabilityCurrentAndNoncurrent
1472000
CY2022Q4 us-gaap Postemployment Benefits Liability Current And Noncurrent
PostemploymentBenefitsLiabilityCurrentAndNoncurrent
1878000
CY2023Q4 payo Severance Pay Fund Non Current
SeverancePayFundNonCurrent
840000
CY2022Q4 payo Severance Pay Fund Non Current
SeverancePayFundNonCurrent
1095000
CY2023Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
80000000
CY2023Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
250000000
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
11064692
CY2023 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
56936000
CY2023 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
5.13
CY2023Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
240179000
CY2023 payo Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
25158086
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
8555000
CY2021Q2 payo Class Of Warrant Or Right Forfeited
ClassOfWarrantOrRightForfeited
723333
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
25914000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
59877000
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-17359000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-33963000
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
8555000
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
25914000
CY2023 us-gaap Loss Contingency Estimated Recovery From Third Party
LossContingencyEstimatedRecoveryFromThirdParty
$140
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
590827000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
563567000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
460582000
CY2023 us-gaap Interest And Fee Income Loans Trade Financing
InterestAndFeeIncomeLoansTradeFinancing
230634000
CY2022 us-gaap Interest And Fee Income Loans Trade Financing
InterestAndFeeIncomeLoansTradeFinancing
55292000
CY2021 us-gaap Interest And Fee Income Loans Trade Financing
InterestAndFeeIncomeLoansTradeFinancing
2702000
CY2023 payo Capital Advance Income
CapitalAdvanceIncome
9642000
CY2022 payo Capital Advance Income
CapitalAdvanceIncome
8764000
CY2021 payo Capital Advance Income
CapitalAdvanceIncome
10119000
CY2023 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
240276000
CY2022 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
64056000
CY2021 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
12821000
CY2023 us-gaap Revenues
Revenues
831103000
CY2022 us-gaap Revenues
Revenues
627623000
CY2021 us-gaap Revenues
Revenues
473403000
CY2023 us-gaap Revenues
Revenues
831103000
CY2022 us-gaap Revenues
Revenues
627623000
CY2021 us-gaap Revenues
Revenues
473403000
CY2023 payo Schedule Of Deferred Customer Acquisition Costs
ScheduleOfDeferredCustomerAcquisitionCosts
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:86.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:86.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Opening balance as of December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,245</p></td></tr><tr><td style="vertical-align:bottom;width:86.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions to deferred customer acquisition costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,406</p></td></tr><tr><td style="vertical-align:bottom;width:86.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amortization of deferred customer acquisition costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (10,038)</p></td></tr><tr><td style="vertical-align:bottom;width:86.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ending balance as of December 31, 2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,613</p></td></tr><tr><td style="vertical-align:bottom;width:86.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:86.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Opening balance as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,366</p></td></tr><tr><td style="vertical-align:bottom;width:86.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Additions to deferred customer acquisition costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 11,476</p></td></tr><tr><td style="vertical-align:bottom;width:86.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Amortization of deferred customer acquisition costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"> (12,597)</p></td></tr><tr><td style="vertical-align:bottom;width:86.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ending balance as of December 31, 2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.34%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10,245</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><span style="font-size:1pt;margin-left:0pt;visibility:hidden;">​</span></p>
CY2022Q4 payo Deferred Customer Acquisition Costs
DeferredCustomerAcquisitionCosts
10245000
CY2023 payo Deferred Customer Acquisition Costs Additions
DeferredCustomerAcquisitionCostsAdditions
9406000
CY2023 payo Deferred Customer Acquisition Costs Amortization
DeferredCustomerAcquisitionCostsAmortization
10038000
CY2023Q4 payo Deferred Customer Acquisition Costs
DeferredCustomerAcquisitionCosts
9613000
CY2021Q4 payo Deferred Customer Acquisition Costs
DeferredCustomerAcquisitionCosts
11366000
CY2022 payo Deferred Customer Acquisition Costs Additions
DeferredCustomerAcquisitionCostsAdditions
11476000
CY2022 payo Deferred Customer Acquisition Costs Amortization
DeferredCustomerAcquisitionCostsAmortization
12597000
CY2022Q4 payo Deferred Customer Acquisition Costs
DeferredCustomerAcquisitionCosts
10245000
CY2023 payo Schedule Of Transaction Costs
ScheduleOfTransactionCosts
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:33.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;"> December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Bank and processor fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 87,972</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 85,015</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 76,868</p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Network fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18,212</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 13,617</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9,162</p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chargebacks and operational losses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,273</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,837</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,917</p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Card costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,858</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,834</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,323</p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Capital advance costs, net of recoveries</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,679</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 4,526</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,363</p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 297</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,843</p></td></tr><tr><td style="vertical-align:bottom;width:64.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Total transaction costs </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 122,291</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 110,165</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 101,476</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p>
CY2023 payo Bank And Processor Fees
BankAndProcessorFees
87972000
CY2022 payo Bank And Processor Fees
BankAndProcessorFees
85015000
CY2021 payo Bank And Processor Fees
BankAndProcessorFees
76868000
CY2023 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
18212000
CY2022 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
13617000
CY2021 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
9162000
CY2023 payo Chargebacks And Operational Losses
ChargebacksAndOperationalLosses
7273000
CY2022 payo Chargebacks And Operational Losses
ChargebacksAndOperationalLosses
3837000
CY2021 payo Chargebacks And Operational Losses
ChargebacksAndOperationalLosses
3917000
CY2023 payo Card Costs
CardCosts
1858000
CY2022 payo Card Costs
CardCosts
1834000
CY2021 payo Card Costs
CardCosts
2323000
CY2023 payo Capital Advance Costs
CapitalAdvanceCosts
6679000
CY2022 payo Capital Advance Costs
CapitalAdvanceCosts
4526000
CY2021 payo Capital Advance Costs
CapitalAdvanceCosts
6363000
CY2023 payo Other Transaction Costs
OtherTransactionCosts
297000
CY2022 payo Other Transaction Costs
OtherTransactionCosts
1336000
CY2021 payo Other Transaction Costs
OtherTransactionCosts
2843000
CY2023 payo Transaction Costs
TransactionCosts
122291000
CY2022 payo Transaction Costs
TransactionCosts
110165000
CY2021 payo Transaction Costs
TransactionCosts
101476000
CY2023 payo Number Of Stock Based Compensation Incentive Plans
NumberOfStockBasedCompensationIncentivePlans
3
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0315
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0061
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0108
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.57
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.50
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
2.252
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
7.131
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
25246000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
26105000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
17102000
CY2023 payo Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Intrinsic Value Tax Benefit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodIntrinsicValueTaxBenefit
1201000
CY2022 payo Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Intrinsic Value Tax Benefit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodIntrinsicValueTaxBenefit
1944000
CY2021 payo Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Intrinsic Value Tax Benefit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodIntrinsicValueTaxBenefit
1401000
CY2023 payo Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercises In Period Intrinsic Value Tax Benefit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodIntrinsicValueTaxBenefit
0
CY2022 payo Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercises In Period Intrinsic Value Tax Benefit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodIntrinsicValueTaxBenefit
3682000
CY2021 payo Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Exercises In Period Intrinsic Value Tax Benefit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodIntrinsicValueTaxBenefit
4054000
CY2023 payo Employee Stock Purchase Plan Maximum Annual Deduction Amount
EmployeeStockPurchasePlanMaximumAnnualDeductionAmount
25000
CY2023 payo Employee Stock Ownership Plan Term Of Offering Period
EmployeeStockOwnershipPlanTermOfOfferingPeriod
P6M
CY2023Q4 payo Employee Stock Ownership Plan Minimum Purchase Price Of Shares As Percentage Of Closing Sales Price
EmployeeStockOwnershipPlanMinimumPurchasePriceOfSharesAsPercentageOfClosingSalesPrice
0.85
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.34
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
65767000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
52149000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37012000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
133061000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
13266000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-27181000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-525000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-11648000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1942000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
132536000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1618000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25239000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
37633000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1066000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1298000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
380000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
464000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
11394000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
11409000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
9463000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
50325000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
12855000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
9927000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-10508000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-351000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-263000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
731000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-1216000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11122000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
731000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1216000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39203000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13586000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8711000
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.30
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
8.39
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
27833000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
340000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5300000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
655000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
378000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1023000
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
456000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-2494000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-1213000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-9749000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5258000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3329000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
13053000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
5725000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
7161000
CY2023 payo Non Deductible Warrant Revaluation
NonDeductibleWarrantRevaluation
-3723000
CY2022 payo Non Deductible Warrant Revaluation
NonDeductibleWarrantRevaluation
-7132000
CY2021 payo Non Deductible Warrant Revaluation
NonDeductibleWarrantRevaluation
-2483000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
3044000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
1487000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
1806000
CY2023 payo Effective Income Tax Rate Reconciliation Provision To Return Adjustment Amount
EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentAmount
-1090000
CY2022 payo Effective Income Tax Rate Reconciliation Provision To Return Adjustment Amount
EffectiveIncomeTaxRateReconciliationProvisionToReturnAdjustmentAmount
402000
CY2023 payo Effective Income Tax Rate Reconciliation Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationUncertainTaxPositions
7461000
CY2022 payo Effective Income Tax Rate Reconciliation Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationUncertainTaxPositions
7793000
CY2021 payo Effective Income Tax Rate Reconciliation Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationUncertainTaxPositions
4384000
CY2023 payo Effective Income Tax Rate Reconciliation Effect Of Non U.S.Operations Amount
EffectiveIncomeTaxRateReconciliationEffectOfNonU.s.OperationsAmount
2051000
CY2022 payo Effective Income Tax Rate Reconciliation Effect Of Non U.S.Operations Amount
EffectiveIncomeTaxRateReconciliationEffectOfNonU.s.OperationsAmount
1527000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-788000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
302000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
4000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39203000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13586000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8711000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
21248000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
24733000
CY2023Q4 payo Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Transaction Loss Provision
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsTransactionLossProvision
1149000
CY2022Q4 payo Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Transaction Loss Provision
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsTransactionLossProvision
994000
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
6000
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
167000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2083000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7123000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
3154000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
464000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
5258000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
5476000
CY2023Q4 payo Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
3120000
CY2022Q4 payo Deferred Tax Assets Operating Lease Liability
DeferredTaxAssetsOperatingLeaseLiability
385000
CY2023Q4 payo Deferred Tax Assets Capitalized Research And Development
DeferredTaxAssetsCapitalizedResearchAndDevelopment
7426000
CY2022Q4 payo Deferred Tax Assets Capitalized Research And Development
DeferredTaxAssetsCapitalizedResearchAndDevelopment
808000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
43444000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
40150000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19281000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
28424000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
24163000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
11726000
CY2023Q4 payo Deferred Tax Liabilities Contract Assets
DeferredTaxLiabilitiesContractAssets
413000
CY2022Q4 payo Deferred Tax Liabilities Contract Assets
DeferredTaxLiabilitiesContractAssets
443000
CY2023Q4 payo Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
3126000
CY2022Q4 payo Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
506000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
909000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
4415000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
6127000
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
9000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
481000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
8872000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7557000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
15291000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
4169000
CY2023 payo Deferred Tax Assets Valuation Allowance Reversal
DeferredTaxAssetsValuationAllowanceReversal
10553000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17333000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
1389000
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
1752000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
7823000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
24793000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9540000
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1413000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
9206000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17333000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5076000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
4464000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9540000
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
38000
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
50000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
28424000
CY2023 payo Deferred Tax Asset Valuation Allowance Additions
DeferredTaxAssetValuationAllowanceAdditions
972000
CY2023 payo Deferred Tax Asset Valuation Allowance Deductions
DeferredTaxAssetValuationAllowanceDeductions
-10115000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19281000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22394000
CY2022 payo Deferred Tax Asset Valuation Allowance Additions
DeferredTaxAssetValuationAllowanceAdditions
14818000
CY2022 payo Deferred Tax Asset Valuation Allowance Deductions
DeferredTaxAssetValuationAllowanceDeductions
-8788000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
28424000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
93333000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11970000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-33987000
CY2021 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
33632000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
93333000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11970000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-67619000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
361678893
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
348044831
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
202881911
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
30256559
CY2023 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
730266
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
392665718
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
348044831
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
202881911
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33

Files In Submission

Name View Source Status
0001558370-24-001998-index-headers.html Edgar Link pending
0001558370-24-001998-index.html Edgar Link pending
0001558370-24-001998.txt Edgar Link pending
0001558370-24-001998-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
payo-20231231.xsd Edgar Link pending
payo-20231231x10k.htm Edgar Link pending
payo-20231231x10k001.jpg Edgar Link pending
payo-20231231x10k002.jpg Edgar Link pending
payo-20231231x10k008.jpg Edgar Link pending
payo-20231231xex10d23.htm Edgar Link pending
payo-20231231xex10d24.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
payo-20231231xex14d1.htm Edgar Link pending
payo-20231231xex14d1001.jpg Edgar Link pending
payo-20231231xex21d1.htm Edgar Link pending
payo-20231231xex23d1.htm Edgar Link pending
payo-20231231xex31d1.htm Edgar Link pending
payo-20231231xex31d2.htm Edgar Link pending
payo-20231231xex32d1.htm Edgar Link pending
payo-20231231xex32d2.htm Edgar Link pending
payo-20231231xex4d5.htm Edgar Link pending
payo-20231231xex97.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
payo-20231231_def.xml Edgar Link unprocessable
payo-20231231_lab.xml Edgar Link unprocessable
payo-20231231_pre.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
payo-20231231_cal.xml Edgar Link unprocessable
payo-20231231x10k_htm.xml Edgar Link completed